These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36911142)

  • 1. Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study.
    Huang XT; Xie JZ; Chen LH; Cai JP; Chen W; Liang LJ; Zhang N; Yin XY
    Gastroenterol Rep (Oxf); 2023; 11():goad010. PubMed ID: 36911142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
    Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
    Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiofrequency ablation of pancreatic neuroendocrine tumor].
    Hlavsa J; Procházka V; Kala Z; Man M; Andrasina T; Cíhalová M; Válek V; Crha M; Svobodová I; Urbanová L
    Klin Onkol; 2011; 24(3):209-15. PubMed ID: 21717790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term outcomes and prognosis of palliative surgery for malignant bowel obstruction caused by peritoneal metastasis of colorectal cancer].
    Chen PJ; Wang L; Chen N; Lu XY; Wang HS; He X; Wang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1051-1057. PubMed ID: 31770836
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients with non-functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20-year single-center retrospective analysis.
    You T; Tang H; Xu X; Ying H; Sun Z; Cheng Y; Bai C
    J Neuroendocrinol; 2022 Dec; 34(12):e13211. PubMed ID: 36373196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-center experience with pancreatic cystic neuroendocrine tumors.
    Khalil A; Ewald J; Marchese U; Autret A; Garnier J; Niccoli P; Piana G; Poizat F; Giovannini M; Delpero JR; Turrini O
    World J Surg Oncol; 2020 Aug; 18(1):208. PubMed ID: 32799893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
    Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
    J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
    Bertani E; Fazio N; Radice D; Zardini C; Grana C; Bodei L; Funicelli L; Ferrari C; Spada F; Partelli S; Falconi M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):981-989. PubMed ID: 27613553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival and prognostic factors analysis of primitive neuroectodermal tumor].
    Shen J; Yuan Y; Hu K; Lian X; Hou XR; Sun S; Yan JF; Liu ZK; Zhang FQ
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):614-618. PubMed ID: 30139033
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?
    Thornblade LW; Warner SG; Melstrom L; Ituarte PHG; Chang S; Li D; Fong Y; Singh G
    Surgery; 2021 Jun; 169(6):1417-1423. PubMed ID: 33637345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR activation in well differentiated pancreatic neuroendocrine tumors: a retrospective study on 34 cases.
    Zhou CF; Ji J; Yuan F; Shi M; Zhang J; Liu BY; Zhu ZG
    Hepatogastroenterology; 2011; 58(112):2140-3. PubMed ID: 22024086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis.
    Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM
    HPB (Oxford); 2018 Mar; 20(3):277-284. PubMed ID: 28964630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
    Zhang J; Peng CS; Tian YH
    Clin Interv Aging; 2019; 14():1419-1432. PubMed ID: 31496669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors.
    Morgan RE; Pommier SJ; Pommier RF
    Surgery; 2018 Jan; 163(1):218-225. PubMed ID: 29103583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.
    Chawla A; Williams RT; Sich N; Clancy T; Wang J; Ashley S; Pezzi C; Swanson R
    J Surg Oncol; 2018 Nov; 118(6):983-990. PubMed ID: 30212595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and Late Complications After Surgery for MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Nell S; Borel Rinkes IHM; Verkooijen HM; Bonsing BA; van Eijck CH; van Goor H; de Kleine RHJ; Kazemier G; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; Vriens MR;
    Ann Surg; 2018 Feb; 267(2):352-356. PubMed ID: 27811505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor.
    Xu SS; Xu HX; Wang WQ; Li S; Li H; Li TJ; Zhang WH; Liu L; Yu XJ
    World J Gastroenterol; 2019 Nov; 25(41):6248-6257. PubMed ID: 31749595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET.
    Lombardi M; De Lio N; Funel N; Sardella C; Russo D; Urbani C; Rossi G; Campani D; Martino E; Marcocci C; Boggi U; Bogazzi F
    J Endocrinol Invest; 2015 Jun; 38(6):605-13. PubMed ID: 25501604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.